Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study
Saved in:
Published in: | Haematologica (Roma) Vol. 107; no. 6; pp. 1470 - 1473 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Italy
Fondazione Ferrata Storti
01-06-2022
Ferrata Storti Foundation |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Bibliography: | Disclosures Study data were collected and managed using REDCAP (Research Electronic Data Capture), a web-based software platform designed to support data capture for research studies. The data presented in this study are not available. Study protocol can be required to the corresponding author (luca.laurenti@unicatt.it). II, GR, AV, MC, MM, RM, RM, MG, EP, FMQ, FA, RC, MD, CI, AMF, AP, AR, VA, DDS, AT, FA, GDP, LS, FRM, AT, LT, MP, RF, PG, AC and LL collected the data; AP performed the statistical analysis. All the authors reviewed the manuscript for important intellectual contents, approved the final version of the manuscript and supervised the project. Contributions AV has participated in scientific board meetings held by Janssen; LT has participated in scientific board meetings and has received funding from Janssen. All other authors have no conflicts of interest to disclose. Data sharing statement |
---|---|
ISSN: | 0390-6078 1592-8721 |
DOI: | 10.3324/haematol.2021.280325 |